A biotech firm just made waves in crypto adoption. Sonnet BioTherapeutics closed a merger deal with Hyperliquid Strategies Inc., pivoting hard into digital assets with an $888 million treasury focused on HYPE tokens. The allocation breakdown? Roughly two-thirds goes into HYPE itself, while the remaining third stays in traditional USD. This kind of corporate treasury move signals growing institutional confidence in alternative assets beyond the usual BTC/ETH playbook. Legacy pharma companies diversifying into blockchain infrastructure tokens — that's a storyline worth watching as traditional finance continues testing the waters.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
23 Likes
Reward
23
9
Repost
Share
Comment
0/400
BTCRetirementFund
· 7h ago
Biopharmaceutical companies all in on HYPE? This move is really bold, even crazier than when it was Tesla.
View OriginalReply0
GhostChainLoyalist
· 12-03 18:33
Biopharmaceutical companies all in on HYPE? This pace is a bit intense—who would have dared to do this two or three years ago?
View OriginalReply0
LayerHopper
· 12-02 23:52
Why is it still this trap... TradFi just wants to play with crypto, do they really think that 8 eights can wash their money clean?
View OriginalReply0
GateUser-6bc33122
· 12-02 23:52
Biopharmaceutical company playing with coins? This move is a bit harsh, directly betting 88.8 billion on HYPE, TradFi is really in a hurry.
View OriginalReply0
SeeYouInFourYears
· 12-02 23:50
Traditional pharmaceutical companies are going all in on alts directly, how much do they look down on BTC, haha.
View OriginalReply0
LiquidityNinja
· 12-02 23:44
888 million entering HYPE? This traditional pharmaceutical company is playing quite aggressively, directly ditching the old tricks of BTC/ETH.
View OriginalReply0
ConfusedWhale
· 12-02 23:42
Traditional pharmaceutical companies have started to play with HYPE, this rhythm is a bit extreme.
View OriginalReply0
blockBoy
· 12-02 23:36
$88 billion all in HYPE? Traditional pharmaceutical companies are betting their entire fortunes on this, that's incredibly bold.
View OriginalReply0
ChainWallflower
· 12-02 23:23
888 million is smashing HYPE... Are traditional pharma starting to do this trap? Can't keep up with the rhythm of encryption native.
A biotech firm just made waves in crypto adoption. Sonnet BioTherapeutics closed a merger deal with Hyperliquid Strategies Inc., pivoting hard into digital assets with an $888 million treasury focused on HYPE tokens. The allocation breakdown? Roughly two-thirds goes into HYPE itself, while the remaining third stays in traditional USD. This kind of corporate treasury move signals growing institutional confidence in alternative assets beyond the usual BTC/ETH playbook. Legacy pharma companies diversifying into blockchain infrastructure tokens — that's a storyline worth watching as traditional finance continues testing the waters.